US Patent 11760773 Small molecule drug conjugates of gemcitabine monophosphate
Patent 11760773 was granted and assigned to MaveriX Oncology, Inc. on September, 2023 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11760773 Small molecule drug conjugates of gemcitabine monophosphate
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
